ViE Awards 2016

 

The 9th Vaccine Industry Excellence (ViE) Awards provide a time and a place to celebrate the industry’s most outstanding achievements.
The awards are positioned to identify and reward those organizations and individuals who have demonstrated an unparalleled ability
to succeed and to continually set standards of excellence and advocacy over the previous 12 months. 

 

Important dates:

 

December 11, 2015
 

January 22nd, 2016
 

February 7th, 2016
 

March 1, 2016
 

March 29, 2016
 

Nominations are open 
 

Nominations close
 

Nominated organizations announced publicly -  VOTING IS NOW OPEN  
 

Award submissions provided to Scientific Advisory Board & online voting closes
 

Winners are announced at the 9th ViE Awards Ceremony & Gala Dinner 
 

 

Judging Panel and Scoring System

 

The ViE Awards prides itself on its judging panel composed of the members of our scientific advisory board. Each of the jusdges, who are senior industry representatives from governmental organizations, academia, industry wide experts and affiliate member associations, pharmaceutical and biotech,  are chosen for their knowledge, objectivity and credibility:

Dr Gregory A. Poland , Director of Mayo Vaccine Research Group, Mayo Clinic

Dr Cyril Gay, Senior National Program Leader, Office of National Programs, USDA

Dr Michael Watson, VP Vaccination Policy & Advocacy, Sanofi Pasteur

Dr Bruce Gellin , Deputy Assistant Secretary for Health & Director, NVPO

Dr George Siber, Exec Director, Chair of Scientific Advisory Board, CSO, Genocea Biosciences Inc

Dr Leonard Friedland, VP, Scientific Affairs and Public Health Vaccines, North America, GSK

Dr Luis Jodar, Vice President, Vaccines, Global, Medicines Development group and Scientific Affairs, Pfizer

 

 

Notation: At the end of the submission period, ending on January 22nd, the board will receive a copy of each submission per award category. 

Each judge, will be requested to mark each submission form against each criteria. The score for each category will range between 0 and 10. Scores are then collated by the ViE Awards team. The organization, team or person collecting the maximum number of points per category will be the winner of the awards. A strict embargo on results will be imposed and the results will only be revealed during the evening Awards ceremony on March 29, 2016. 

 

DOWNLOAD THE AWARDS CRITERIA AND SUBMISSION INFORMATION HERE

 

Award Categories

 

Best Clinical Trial Network OR Site - ViE Awards at the World Vaccine Congress US 2015

The Best Clinical Trial Site OR Network category is open to international trial sites and their network owners

> Matching clinical development needs through a complete programmatic assessment
> Supportive of multiple and diverse clinical phase and outcomes trials for vaccines
> Methods of performance improvement or introduction of new services 
> Rapid enrolment across a variety of vaccine ranges and outstanding study subject retention
> Reaching of milestones and final / ongoing outcomes / trials

 

Best CRO - ViE Awards at the World Vaccine Congress US 2015

The Best Contract Research Organization category is open to international CROs

> The range of services provided in niche and core therapeutic areas 
> Methods of performance improvement or introduction of new services 
> Attention to and quality of relationships with clients 
> Reaching of milestones and final / ongoing outcomes 
> Building and maintaining existing and long-term partnerships

 

Best CMO - ViE Awards at the World Vaccine Congress US 2015


The Best Contract Manufacturing Organization category is open to international CMOs

> The range of services provided in niche and core therapeutic areas 
> Methods of performance improvement or introduction of new services 
> Attention to and quality of relationships with clients 
> Reaching of milestones and final / ongoing outcomes 
> Building and maintaining existing and long-term partnerships

 

Best Technological Development - ViE Awards at the World Vaccine Congress US 2015

Best Production/Process Development

> Demonstration of an ongoing commitment to provide production or process technology globally and in reducing lead times for its customers
> Demonstration of an end-to-end suite of solutions to customers 
> Demonstration of outstanding thought leadership in spearheading innovation 
> Examples of raising the bar of process or production standards 
> Attention to and quality of relationships with clients

 

Best Vaccine Partnership/Alliance - ViE Awards at the World Vaccine Congress US 2015

The Best Academic Research Team category is open to research institutes and universities 

> Candidates addressing current unmet medical needs 
> Significant potential for vast geographical and market reach 
> Research possession of a novel mode of action or technology 
> Progress through pre- / clinical phases and / or study results achieved
> Details of significant grants ie. donors / amounts achieved supporting research

 

Best Academic Research Team - ViE Awards at the World Vaccine Congress US 2015

The Best Early-Stage Vaccine Biotech category is open to global early-stage Biotechs

> Ability to move the business from early stage to a more mature company
> Quality and diversity of the vaccine pipeline and candidates
> Advancements in taking a new product to market or through clinical stages
> Meaningful licensing or partnership deals
> Securing significant new funds for growth

 

Best Financing Deal - ViE Awards at the World Vaccine Congress US 2015

The Biotech CEO of the Year category is open to Chief Executives from all sized Biotechs 

>   Degree of outstanding commitment to disease prevention and treatment  
> Level of exemplary leadership throughout the year 
> Contribution to company performance, communication and vision 
> Influence within the industry and communication of a shared vision
> Achievements made with regards to company positioning and status 

 

Best Vaccine License - ViE Awards at the World Vaccine Congress US 2015

The Best Pharma Company category is open to international Pharmaceutical organizations

> Size and range of the overall vaccine pipeline 
> Mix across development phases 
> Spread across innovation and lower risk candidate development 
> Commitment to R&D productivity model implementation 
> Current and future market potential and value for the pipeline 

 

Best Early-Stage Biotech - ViE Awards at the World Vaccine Congress US 2015

The Best Therapeutic Vaccine (approved or in development) category is open to all vaccine organizations

> Vaccine candidate addresses current unmet medical needs 
> Candidate shows significant potential for vast geographical and market reach 
> Candidate possesses a novel mode of action or technology 
> Progress made to-date through clinical trials and / or achieved milestones 
> Advanced efficacy, safety and risk management data where appropriate

 

Best Biotech CEO - ViE Awards at the World Vaccine Congress US 2015

The Best Prophylactic Vaccine (approved or in development) category is open to all vaccine organizations 

> Vaccine candidate addresses current unmet medical needs 
> Candidate shows significant potential for vast geographical and market reach 
> Candidate possesses a novel mode of action or technology 
> Progress made to-date through clinical trials and / or achieved milestones 
> Advanced efficacy, safety and risk management data where appropriate